Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PPD, Inc.
  6. Summary
    PPD   US69355F1021

PPD, INC.

(PPD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
46.46(c) 46.44(c) 46.5(c) 46.52(c) 46.58(c) Last
1 837 534 2 055 937 875 518 1 481 248 944 521 Volume
+0.09% -0.04% +0.13% +0.04% +0.13% Change
More quotes
Financials (USD)
Sales 2021 5 437 M - -
Net income 2021 362 M - -
Net Debt 2021 3 026 M - -
P/E ratio 2021 46,2x
Yield 2021 0,01%
Sales 2022 5 902 M - -
Net income 2022 499 M - -
Net Debt 2022 2 566 M - -
P/E ratio 2022 34,2x
Yield 2022 -
Capitalization 16 359 M 16 359 M -
EV / Sales 2021 3,57x
EV / Sales 2022 3,21x
Nbr of Employees 26 000
Free-Float 61,4%
More Financials
Company
PPD, Inc. provides drug development services to the biopharmaceutical industry. The Company provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The CompanyÔÇÖs business segments include Clinical Development Services segment and Laboratory Services segment. Its Clinical Development Services... 
More about the company
Ratings of PPD, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about PPD, INC.
06/08ANALYST RECOMMENDATIONS : Amgen, Biogen, Halfords, J Sainsbury, Uber...
06/07CORRECTION : Mizuho Securities Maintains Price Target for PPD at $47.50, Reitera..
MT
06/07PPDá : Mizuho Securities Adjusts PPD Price Target to $38 From $47.50, Maintains ..
MT
05/27PPDá : Named ‘Most Innovative CRO' by Triangle Business Journal
BU
05/24PPDá : Opens Multipurpose Clinical Research Laboratory in Suzhou, China
BU
05/20PPDá : CRO Leadership Awards Recognize PPD for Excellence for 10th Consecutive Y..
BU
05/13MOVES-Deutsche Bank hires investment banking veteran Priyanka Verma in health..
RE
05/06PPDá : Named “Best CRO” at Vaccine Industry Excellence Awards
BU
04/28PPD, INC.á : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
04/28PPDá : JPMorgan Downgrades PPD to Neutral from Overweight, Lifts PT to $48 From ..
MT
04/28PPDá : to Expand Testing Capability at Irish Laboratory
MT
04/28PPDá : to Expand GMP Lab in Ireland to Enhance Biopharmaceutical Testing Capabil..
BU
04/27PPDá : Tops Street View on Higher Earnings, Revenue
MT
04/27PPD, INC.á : Results of Operations and Financial Condition, Financial Statements..
AQ
04/27PPDá : Earnings Flash (PPD) PPD Posts Q1 Revenue $1.38B
MT
More news
News in other languages on PPD, INC.
04/16Pump / dump #7
04/16STOCK MARKET PARIS : La croissance chinoise s'invite chez les sorcières
04/16EN DIRECT DES MARCHESá : L'Oréal, FDJ, Fnac Darty, HelloFresh, Daimler, GSK, Sco..
04/15Thermo Fisher übernimmt Auftragsforscher PPD für 21 Mrd Dollar
04/15DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 15.04.2021 - 15.15 Uhr
More news
Analyst Recommendations on PPD, INC.
More recommendations
Chart PPD, INC.
Duration : Period :
PPD, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PPD, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 47,55 $
Last Close Price 46,58 $
Spread / Highest target 3,05%
Spread / Average Target 2,07%
Spread / Lowest Target 0,90%
EPS Revisions
Managers and Directors
NameTitle
David S. Simmons Chairman & Chief Executive Officer
Christopher G. Scully CFO, Treasurer, Executive VP & Assistant Secretary
David Johnston Executive VP-Global Clinical Development
Karen Kaucic Chief Medical Officer & Executive Vice President
Rob Petrie Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PPD, INC.36.12%16 359
MODERNA, INC.109.49%87 874
LONZA GROUP AG16.32%54 656
IQVIA HOLDINGS INC.35.87%46 658
CELLTRION, INC.-26.04%32 458
SEAGEN INC.-10.60%28 416